C. Sarrazin

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Real-Time Tissue Elastography Versus FibroScan for Noninvasive Assessment of Liver Fibrosis in Chronic Liver Disease

Mireen Friedrich‐Rust, A. Schwarz, Mark Ong et al. · Ultraschall in der Medizin - European Journal of Ultrasound · 2009 · 71 citations

1416 FALDAPREVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONIC HCV GENOTYPE-1 TREATMENT-NAÏVE PATIENTS: FINAL RESULTS FROM STARTVERSO1, A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL

Peter Ferenci, Tarik Asselah, Graham R. Foster et al. · Journal of Hepatology · 2013 · 54 citations

Hepatitis C, Viral Hepatitis, Immunodeficiencies +10

6 EXTRACORPOREAL LIVER SUPPORT BY FRACTIONATED PLASMA SEPARATION AND ADSORPTION (PROMETHEUS) IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (HELIOS STUDY): A PROSPECTIVE RANDOMIZED CONTROLLED MULTICENTER STUDY

Kareem Rifai, Andreas Kribben, Guido Gerken et al. · Journal of Hepatology · 2010 · 50 citations

Hepatology, Liver Physiology, Helios Study +5

No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct‐acting antivirals for hepatitis C in a large real‐world cohort

Victoria T. Mücke, Marcus M. Mücke, Kai‐Henrik Peiffer et al. · Alimentary Pharmacology & Therapeutics · 2017 · 42 citations